EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 239 filers reported holding EDITAS MEDICINE INC in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $129,000 | +25.2% | 3,143 | +72.5% | 0.01% | +40.0% |
| Q2 2021 | $103,000 | +33.8% | 1,822 | -0.4% | 0.01% | +25.0% |
| Q1 2021 | $77,000 | -54.7% | 1,830 | -70.0% | 0.00% | -63.6% |
| Q3 2020 | $170,000 | – | 6,091 | +121720.0% | 0.01% | – |
| Q2 2020 | $0 | -100.0% | 5 | -99.2% | 0.00% | -100.0% |
| Q1 2020 | $13,000 | -23.5% | 653 | +11.1% | 0.00% | 0.0% |
| Q4 2019 | $17,000 | +466.7% | 588 | +398.3% | 0.00% | – |
| Q2 2019 | $3,000 | -76.9% | 118 | -79.3% | 0.00% | -100.0% |
| Q4 2018 | $13,000 | -99.8% | 571 | +189.8% | 0.00% | 0.0% |
| Q2 2018 | $7,058,000 | +176350.0% | 197 | +68.4% | 0.00% | – |
| Q1 2018 | $4,000 | -50.0% | 117 | -58.7% | 0.00% | -100.0% |
| Q4 2017 | $8,000 | +300.0% | 283 | +121.1% | 0.00% | – |
| Q2 2017 | $2,000 | -50.0% | 128 | -31.6% | 0.00% | – |
| Q1 2017 | $4,000 | -42.9% | 187 | -59.2% | 0.00% | -100.0% |
| Q4 2016 | $7,000 | – | 458 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NIA IMPACT ADVISORS, LLC | 54,615 | $4,897,000 | 2.55% |
| Capital Impact Advisors, LLC | 130,000 | $9,114,000 | 2.24% |
| ARK Investment Management | 10,125,564 | $709,903,000 | 1.89% |
| Nikko Asset Management Americas, Inc. | 4,388,143 | $307,653,000 | 1.75% |
| Spectrum Planning & Advisory Services Inc. | 17,522 | $1,228,000 | 1.32% |
| DDD Partners, LLC | 79,527 | $5,576,000 | 1.10% |
| Brevan Howard Capital Management LP | 76,420 | $5,358,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 538,721 | $37,770,000 | 0.75% |
| DC Investments Management, LLC | 3,627 | $254,000 | 0.63% |
| Haafor (Singapore) Pte. Ltd. | 4,761 | $334,000 | 0.62% |